Product Information

BUDESONIDE 2 MG RECTAL FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $9.3919 per GM under NDC 45802062786. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on Apr 12, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUDESONIDE 2 MG RECTAL FOAM

budesonide
$9.3919per GM

Strength

2 mg/1

NDC

45802062786

Classification

Generic

Dosage Form

AEROSOL, FOAM

Route

RECTAL

Effective Date

11/18/2026

Active Ingredients

BUDESONIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215328

FDA Approved

4/12/2023

TE Code

AB

On Market Since

4/17/2023

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for BUDESONIDE 2 MG RECTAL FOAM has been published 136 times since Apr 17, 2024, and over the history we have for it it has risen 13.7%. The table below summarizes its recorded NADAC range and movement.

Current price$9.3919 per GM
All-time high$9.6044 (Nov 11, 2026)
All-time low$7.0795 (Aug 21, 2024)
52-week high$9.6044
52-week low$9.3010
Median price$9.3010
Average price$8.8949
Largest weekly change+6.7% (Oct 23, 2024)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

-2.2%

1M

-2.2%

3M

-1.6%

6M

+0.9%

1Y

+1.0%

3Y

N/A

5Y

N/A

All

+13.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUDESONIDE 2 MG RECTAL FOAM?

The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE 2 MG RECTAL FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $9.3919 per GM (NDC 45802062786), effective Nov 18, 2026.

How has the price of BUDESONIDE 2 MG RECTAL FOAM changed over time?

Over the history we have for it, the NADAC for BUDESONIDE 2 MG RECTAL FOAM has risen 13.7%. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for BUDESONIDE 2 MG RECTAL FOAM?

Since Apr 17, 2024, the NADAC for BUDESONIDE 2 MG RECTAL FOAM has ranged from a low of $7.0795 (Aug 21, 2024) to a high of $9.6044 (Nov 11, 2026), with a median of $9.3010 per GM.

Are there cheaper alternatives to BUDESONIDE 2 MG RECTAL FOAM?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUDESONIDE 2 MG RECTAL FOAM in a comparable dosage form, but none are currently priced below it.

Who manufactures BUDESONIDE 2 MG RECTAL FOAM?

BUDESONIDE 2 MG RECTAL FOAM (NDC 45802062786) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.